Variant report
Variant | esv1798810 |
---|---|
Chromosome Location | chr5:60001832-60012235 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:59998583..60001649-chr5:60008376..60010857,3 | K562 | blood: | |
2 | chr5:59990643..59992382-chr5:60006988..60008746,2 | K562 | blood: | |
3 | chr5:59997848..60001535-chr5:60002216..60006200,5 | K562 | blood: | |
4 | chr5:59994459..59997087-chr5:60000577..60002875,2 | K562 | blood: | |
5 | chr5:60006154..60007664-chr5:60138828..60140875,2 | MCF-7 | breast: | |
6 | chr5:59998145..60001535-chr5:60003151..60006329,3 | K562 | blood: | |
7 | chr5:59996423..59998684-chr5:60001090..60003995,3 | MCF-7 | breast: | |
8 | chr5:59994459..59997012-chr5:59999943..60002207,3 | K562 | blood: | |
9 | chr5:59998796..60001597-chr5:60005006..60007976,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000164181 | chromatin interactions |
ENSG00000035499 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566817997 | chr5:60001843-60001844 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs35108782 | chr5:60001844-60001845 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs75114046 | chr5:60001899-60001900 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs58971637 | chr5:60001936-60001937 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs144334238 | chr5:60002008-60002009 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs111267646 | chr5:60002053-60002054 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs145458518 | chr5:60002054-60002055 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs116551488 | chr5:60002066-60002067 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs538568984 | chr5:60002067-60002068 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs558783993 | chr5:60002193-60002194 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs55871236 | chr5:60002203-60002204 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs79720661 | chr5:60002211-60002212 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs541259868 | chr5:60002254-60002255 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs192237520 | chr5:60002309-60002310 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs575030429 | chr5:60002371-60002372 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs574164243 | chr5:60002373-60002374 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs10708094 | chr5:60002378-60002379 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs184220138 | chr5:60002466-60002467 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs72644102 | chr5:60002488-60002489 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs73759384 | chr5:60002500-60002501 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs552614971 | chr5:60002533-60002534 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs34840362 | chr5:60002552-60002553 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs560023378 | chr5:60002730-60002731 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs200248453 | chr5:60002765-60002766 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs188066540 | chr5:60002774-60002775 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs560053882 | chr5:60002794-60002795 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs568313976 | chr5:60002901-60002902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62370884 | chr5:60002996-60002997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527291113 | chr5:60003003-60003004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535948782 | chr5:60003044-60003045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112651399 | chr5:60003084-60003085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57674742 | chr5:60003111-60003112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112807618 | chr5:60003185-60003186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192819370 | chr5:60003244-60003245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538602703 | chr5:60003309-60003310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143450188 | chr5:60003457-60003458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78782906 | chr5:60003458-60003459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566003158 | chr5:60003460-60003461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534909313 | chr5:60003506-60003507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs151104088 | chr5:60003606-60003607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574644382 | chr5:60003607-60003608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543948832 | chr5:60003634-60003635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184382299 | chr5:60003662-60003663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370972137 | chr5:60003664-60003665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375648177 | chr5:60003665-60003666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35726017 | chr5:60003675-60003676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112207084 | chr5:60003679-60003680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189611457 | chr5:60003715-60003716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145091459 | chr5:60003719-60003720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546214502 | chr5:60003738-60003739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 21272361 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:60001800-60002600 | Weak transcription | Placenta | Placenta |
2 | chr5:60002600-60003400 | Enhancers | Placenta | Placenta |
3 | chr5:60003400-60005800 | Weak transcription | Placenta | Placenta |
4 | chr5:60005800-60006200 | Enhancers | Placenta | Placenta |
5 | chr5:60012000-60012200 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |